Clinical Characteristics Correlate With Outcomes of Immunotherapy in Advanced Non-Small Cell Lung Cancer

Considering the existing indicators are not sufficient to predict the patient's response to immune checkpoint inhibitors (ICIs), we conducted this study to evaluate the efficacy and safety of ICIs in advanced non-small cell lung cancer (NSCLC) patients, and to determine prognostic factors of IC...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Cancer
Auteurs principaux: Huang, Lan, Li, Li, Zhou, Yingxu, Yang, Zhaoyang, Wang, Meng, Gao, Yina, Yang, Yang, Yang, Fang, Liu, Bao, Hong, Xuan, Chen, Gongyan
Format: Artigo
Langue:Inglês
Publié: Ivyspring International Publisher 2020
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646175/
https://ncbi.nlm.nih.gov/pubmed/33193876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.49213
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires